Phibro Animal Health (PAHC) Share-based Compensation (2018 - 2026)
Phibro Animal Health (PAHC) posted quarterly Share-based Compensation of $179000.0 for Q1 2026, little changed year-over-year from $179000.0 in Q1 2025, and down 0.56% quarter-over-quarter from $180000.0 in Q4 2025.
Phibro Animal Health (PAHC) Share-based Compensation (2018 - 2026) Analysis & Trends
Phibro Animal Health's Share-based Compensation history runs 7 years deep, the most recent figure standing at $179000.0 for Q1 2026.
- In Q1 2026, Share-based Compensation changed 0.0% year-over-year to $179000.0; the TTM figure through Mar 2026 stood at $877000.0 (up 22.32% YoY), while the FY2025 annual figure was $717000.0, up 50.95% from the prior year.
- Share-based Compensation for Q1 2026 stood at $179000.0, down from $180000.0 in the prior quarter.
- The five-year high for Share-based Compensation was $339000.0 in Q3 2025, with the low at $80000.0 in Q4 2023.
- The 4-year median for Share-based Compensation is $179000.0 (2024), against an average of $171818.2.
- The sharpest annual moves came in 2024 and 2025: Share-based Compensation surged 125.0% in 2024, then changed 0.0% in 2025.
- Phibro Animal Health's Share-based Compensation stood at $80000.0 in 2023, then soared by 125.0% to $180000.0 in 2024, then changed by 0.0% to $180000.0 in 2025, then declined by 0.56% to $179000.0 in 2026.
- Business Quant data shows PAHC's Share-based Compensation at $179000.0 in Q1 2026, $180000.0 in Q4 2025, and $339000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 40.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 26.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 114.12 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 19.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 30.40 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 65.00 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 7.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 125.68 Mn | 411,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 179,000.00 |
| Mar 31, 2026 | 179,000.00 |
| Dec 31, 2025 | 180,000.00 |
| Dec 31, 2025 | 180,000.00 |
| Sep 30, 2025 | 339,000.00 |
| Sep 30, 2025 | 339,000.00 |
| Jun 30, 2025 | 179,000.00 |
| Jun 30, 2025 | 179,000.00 |
| Mar 31, 2025 | 179,000.00 |
| Mar 31, 2025 | 179,000.00 |
| Dec 31, 2024 | 180,000.00 |
| Dec 31, 2024 | 180,000.00 |
| Sep 30, 2024 | 179,000.00 |
| Sep 30, 2024 | 179,000.00 |
| Jun 30, 2024 | 179,000.00 |
| Jun 30, 2024 | 179,000.00 |
| Mar 31, 2024 | 135,000.00 |
| Mar 31, 2024 | 135,000.00 |
| Dec 31, 2023 | 80,000.00 |
| Dec 31, 2023 | 80,000.00 |